Monday, November 23, 2020

CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.

Cancer shared this article with you from Inoreader
Condition:   CLL Interventions:   Drug: ibrutinib, venetoclax, obinutuzumab;   Drug: ibrutinib, venetoclax Sponsors:   Stichting Hemato-Oncologie voor Volwassenen Nederland;   Nordic Lymphoma Group Not yet recruiting (Source: ClinicalTrials.gov)
View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...